Concepedia

Leif Carlsson

LC

Statistics

Publications

36

Citations

2.6K

H-Index

25

Active since

1985

Affiliations

AstraZeneca (Sweden)(Current)

Masonic Medical Research Laboratory

University of Gothenburg

AstraZeneca (United Kingdom)

Karolinska Institutet

Leif Carlsson is an author at AstraZeneca (Sweden) specializing in medicine, pharmacology, and cardiology.

ORCID

Publications per year

1985–2019

36

Publications

36

Instability and Triangulation of the Action Potential Predict Serious Proarrhythmia, but Action Potential Duration Prolongation Is Antiarrhythmic

Luc M. Hondeghem, Leif Carlsson, Göran Duker · Circulation · 2001 · 505 citations

, , +16

QTU-Prolongation and Torsades de Pointes Induced by Putative Class III Antiarrhythmic Agents in the Rabbit

Leif Carlsson, Olle Almgren, Göran Duker · Journal of Cardiovascular Pharmacology · 1990 · 236 citations

, , +17

Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes

Li‐Ming Gan, Maria Lagerström‐Fermér, Leif Carlsson et al. · Nature Communications · 2019 · 215 citations · Full text

, , +13

Biocompatible, Purified VEGF-A mRNA Improves Cardiac Function after Intracardiac Injection 1 Week Post-myocardial Infarction in Swine

Leif Carlsson, Jonathan Clarke, Christopher Yen et al. · Molecular Therapy — Methods & Clinical Development · 2018 · 176 citations · Full text

, , +14

Electrophysiological Characterization of the Prokinetic Agents Cisapride and Mosapride in Vivo and in Vitro: Implications for Proarrhythmic Potential?

Leif Carlsson, Gregory Amos, Birgit Andersson et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 158 citations

, , +17

1–5 of 36